Eli Lilly and Company has launched “Nujoom Al Ghad”, a 12-month graduate programme aimed at developing UAE national talent and creating career pathways in the pharmaceutical and healthcare sectors.
Starting in December 2026, the programme will provide Emirati graduates with structured rotations across commercial and non-commercial functions. Participants will gain practical experience across different areas of the medicines business while developing an understanding of how pharmaceutical innovation reaches patients and healthcare systems.
Click here to join our WhatsApp channel here
The programme is open to UAE nationals who graduated in 2025 or 2026 from scientific disciplines including pharmacy, biochemistry, biology and related fields. Through exposure to multiple teams, graduates will develop cross-functional skills and gain a broader perspective of the pharmaceutical industry.
Tayllit Aherdan, Vice President & General Manager, Lilly Gulf (UAE, Kuwait and Qatar) said: “The future of healthcare in the UAE will depend not only on scientific innovation, but also on developing the people and capabilities that will help advance it. Nujoom Al Ghad is about creating that opportunity for Emirati talent.”
At the conclusion of the programme, successful participants will have opportunities to pursue longer-term career pathways within the company, supporting the development of the next generation of UAE healthcare and pharmaceutical talent.
Also read: Dubai Blood Donation Drive Supports Patients Living with Thalassemia
